Which Diets Actually Help MS Patients Think More Clearly
A systematic review finds Wahls, ketogenic, and low-calorie Mediterranean diets show the most promise for cognitive function in multiple sclerosis.
Summary
Cognitive decline affects up to 70% of people with multiple sclerosis, yet dietary strategies for managing it remain understudied. This systematic review synthesized evidence from clinical trials and observational studies examining how specific dietary patterns affect cognition in MS patients. Diets evaluated included Mediterranean, modified Paleolithic (Wahls), Swank, ketogenic, and time-restricted eating. The Wahls and Swank diets showed comparable improvements in processing speed and mental cognition. A low-calorie Mediterranean diet improved processing speed and manual dexterity, while standard Mediterranean diet trials showed little cognitive benefit. Small studies on ketogenic and time-restricted eating suggested potential gains but were inconsistent. The authors concluded that dietary interventions hold adjunctive promise but that study heterogeneity and limited high-quality evidence prevent firm recommendations.
Detailed Summary
Cognitive impairment is one of the most burdensome complications of multiple sclerosis, affecting memory, processing speed, and executive function in a large proportion of patients. Despite its prevalence, non-pharmacological strategies such as dietary modification remain poorly characterized. This systematic review addresses that gap by synthesizing available clinical and observational evidence on the diet-cognition relationship in MS.
Researchers from Tabriz University of Medical Sciences identified studies examining several dietary regimens: Mediterranean (three studies), modified Paleolithic or Wahls protocol (three studies), Swank diet (one study), ketogenic diet (two studies), and time-restricted eating (one study). Additional studies assessed overall dietary quality and healthy eating patterns against cognitive outcomes.
Results were mixed but directionally informative. The Wahls and Swank diets produced comparable improvements in processing speed and broader mental cognition. A low-calorie Mediterranean diet variant demonstrated gains in processing speed, manual dexterity, and reduced cognitive complaints, while standard Mediterranean diet trials generally did not reach statistical significance for cognitive outcomes. Ketogenic and time-restricted eating protocols showed potential benefits in small samples, but findings lacked consistency across studies.
For clinicians and patients, these results suggest that caloric restriction combined with anti-inflammatory dietary principles may be more cognitively relevant than diet composition alone. The Wahls protocol, which emphasizes nutrient density and mitochondrial support, stands out as a candidate worthy of larger trials. Mechanistically, these diets may work through reduced neuroinflammation, improved mitochondrial function, and gut-brain axis modulation.
Critical caveats include substantial heterogeneity in study designs, cognitive assessment tools, and intervention durations. Most trials were small and short-term, limiting generalizability. The review was conducted on abstract-level evidence for some studies. Larger, standardized randomized controlled trials are urgently needed before dietary modification can be formally recommended as a cognitive intervention in MS.
Key Findings
- Wahls and Swank diets showed comparable improvements in processing speed and mental cognition in MS patients.
- A low-calorie Mediterranean diet improved processing speed, manual dexterity, and reduced cognitive complaints.
- Standard Mediterranean diet trials generally failed to show significant cognitive benefits in MS.
- Ketogenic and time-restricted eating showed potential but inconsistent cognitive benefits in small studies.
- No single diet generated enough high-quality evidence to warrant a firm clinical recommendation.
Methodology
This is a systematic review of clinical interventional and observational studies evaluating dietary regimens and cognitive outcomes in MS patients. Studies were categorized by diet type and cognitive measure used. The review does not appear to include a formal meta-analysis, limiting quantitative pooling of results.
Study Limitations
This summary is based on the abstract only, as the full text was not available. Study heterogeneity in design, cognitive assessment tools, and intervention duration makes cross-study comparisons unreliable. Most included studies were small, short-term, and of variable methodological quality, preventing strong causal conclusions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: